Form 10-K Kite Pharma, Inc. For: Dec 31
http://archive.fast-edgar.com/20160229/AUAZB22CZC22KTB4222I2ZZ2GQM9ZY22ZZ82
Filed on: February 29, 2016
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ethereum and Arbitrum Price Prediction: ARB Rebounds as Remittix Offers a Completely Different Growth Story
- Sebela Pharmaceuticals to Present Positive Phase 3 Tegoprazan Data in Non-Erosive Reflux Disease (NERD) at the American College of Gastroenterology (ACG) 2026 Meeting
- Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share